Immunologic changes in healthy probands and HIV infected patients after oral administration of Staphylococcus aureus 12c: A pilot study

Homeopathy

Volumn 89, Issue 3, 2000, Pages 106-115

  Danninger, T ^a   Gallenberger, K ^a,b   Kraeling, J ^a  

^a NONE   (Germany)

^b NONE   (Germany)

Author keywords

HIV; Immune modulation; Staphylococcal superantigens

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; STAPHYLOCOCCUS AUREUS ANTIGEN 12C; STAPHYLOCOCCUS TOXIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MALE; SERODIAGNOSIS; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE SUBPOPULATION;

EID: 0033854278     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bhj.5800403     Document Type: Article

References (2)

1. Coley WB. Late results of the treatment of inoperable sarcoma by the mixed toxins of erysipelas and Bacillus prodigiosus. Am J Med Sci 1906; 131: 375-430.
2. Ruckdeschel JC, Codish SD, Stranahan A, McKneally MF. Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment. New Engl J Med 1972; 287: 1013-1017.